Related Experiment Video
Updated: Jul 6, 2026

Surgical Correction for Pediatric Epiblepharon and Trichiasis
Published on: July 8, 2025
Keratoconus in children in Tunisia: Epidemiological, clinical and therapeutic features
Sonda Kammoun1, Kmar Maaloul1, Mona Rekik1
1Department of Ophtalmology, Habib Bourguiba University Hospital, University of Sfax, Sfax, Tunisia.
Insights
Pediatric keratoconus (KC) is a severe condition often diagnosed late. Corneal cross-linking (CXL) effectively halts disease progression in children, offering a safe therapeutic option for this vulnerable population.
Area of Science:
- Ophthalmology
- Pediatric Ophthalmology
- Corneal Diseases
Background:
- Pediatric keratoconus (KC) presents unique clinical and therapeutic challenges.
- Early diagnosis and intervention are crucial for managing this progressive corneal condition in children.
Purpose of the Study:
- To delineate the clinical characteristics and treatment outcomes of pediatric keratoconus.
- To evaluate the efficacy of corneal cross-linking (CXL) in stabilizing pediatric KC.
Main Methods:
- Retrospective analysis of pediatric patients (<18 years) diagnosed with KC.
- Data collection included visual acuity, refractive error, keratometry, pachymetry, and treatment modalities.
Main Results:
- The study included 38 eyes from 20 children, with a mean age of 12.8 years.
- Significant visual acuity reduction correlated with corneal opacities and advanced keratoconus stages.
- Corneal cross-linking (CXL) demonstrated an 80% stabilization rate, compared to 64.29% progression in untreated eyes.
Conclusions:
- Pediatric KC is frequently diagnosed at advanced stages, indicating a severe disease course.
- Corneal cross-linking (CXL) is a safe and effective treatment for halting the progression of pediatric keratoconus.
Aim:
To report the clinical and therapeutic particularities of pediatric keratoconus (KC).
Methods:
Retrospective study focusing on patients aged less than 18 years, presenting with KC and followed in a tertiary reference center in Sfax, Tunisia.
Results:
Our study involved 38 eyes of 20 children. We found a mean age of 12.8 years, a family history of keratoconus for 25% of cases and an atopic background in 30% of children. The mean best-corrected visual acuity was 5.3/10, the mean myopia was -6.3D and the mean total astigmatism was -4.9D. The average maximum simulated keratometry (Kmax) was 54.6 D. The visual acuity decrease was correlated with the presence of corneal opacities, with all keratometric indices except Skewed Radial Axes (SRAX) at 3 and 5 mm, with all elevation parameters and those of pachymetry except the delocalization of the thinnest point. 71.1% of eyes were classified as clinical KC and 47% of eyes were classified as Amlser-Krumeich stage 4. 42.1% of eyes were fitted with glasses and 57.9% with contact lenses. Six patients (10 eyes) underwent cross-linking (CXL). We noted an evolution of the KC for 64.29% of eyes not treated with CXL and a stabilization of 80% of eyes treated with CXL. The difference in follow-up parameters between the two groups was significant.
Conclusion:
Pediatric KC is a severe disease, often diagnosed at a late stage. CXL is a safe and effective way to stop the disease.
More Related Videos
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Toxidromes: Clinical Features
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

